On December 2, pharmaceutical giant GlaxoSmithKline quietly halted a clinical trial of SRT501, a concentrated form of resveratrol, which is the much-hyped substance found in red wine grapes.
The reason this matters is that SRT501 had been one of the most closely watched molecules in the Big Pharma pipeline...
(4) Comments | Posted October 9, 2012 | 5:40 PM